financetom
Business
financetom
/
Business
/
US FDA approves syringe version of Argenx's immune disorder drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves syringe version of Argenx's immune disorder drug
Apr 10, 2025 3:16 PM

April 10 (Reuters) - The U.S. Food and Drug

Administration has approved a pre-filled syringe version of

Netherlands-based Argenx SE's blockbuster immune

disorder drug, Vyvgart, giving patients the more convenient

option of at-home self administration, the company said on

Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan to expand offshore wind development into exclusive economic zone
Japan to expand offshore wind development into exclusive economic zone
Mar 11, 2024
TOKYO, March 12 (Reuters) - Japan's government on Tuesday approved a draft amendment to existing legislation to allow for the installation of offshore wind power in exclusive economic zones (EEZ), a milestone towards the country's goal of carbon neutrality by 2050. Japan aims to have 10 gigawatt (GW) of offshore wind power projects by 2030 and up to 45 GW...
CDU, coker shut by leak at TotalEnergies Texas refinery, sources say
CDU, coker shut by leak at TotalEnergies Texas refinery, sources say
Mar 11, 2024
HOUSTON (Reuters) -The coker and small crude distillation unit (CDU) were shut by a leak on the gasoline-producing fluidic catalytic cracker (FCC) at TotalEnergies' 238,000 barrel per day Port Arthur, Texas refinery, people familiar with plant operations said. The 40,000-bpd ACU-2 CDU and 60,000-bpd coker are expected to be shut for one to two days while a clamp is fabricated...
Tesla, rivals get low marks for automated-driving technology
Tesla, rivals get low marks for automated-driving technology
Mar 11, 2024
DETROIT (Reuters) - Tesla's Autopilot and Full Self Driving technology and nine other assisted-driving systems marketed by major automakers received poor ratings from the U.S. Insurance Institute for Highway Safety in a new study released on Tuesday. The IIHS, a safety research arm of the insurance industry, also said there is no evidence that Autopilot or other assisted-driving systems have...
Tesla, rivals get low marks for automated-driving technology
Tesla, rivals get low marks for automated-driving technology
Mar 11, 2024
DETROIT, March 12 (Reuters) - Tesla's Autopilot and Full Self Driving technology and nine other assisted-driving systems marketed by major automakers received poor ratings from the U.S. Insurance Institute for Highway Safety in a new study released on Tuesday. The IIHS, a safety research arm of the insurance industry, also said there is no evidence that Autopilot or other assisted-driving...
Copyright 2023-2025 - www.financetom.com All Rights Reserved